These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 32658388)

  • 1. GBA-Related Parkinson's Disease: Dissection of Genotype-Phenotype Correlates in a Large Italian Cohort.
    Petrucci S; Ginevrino M; Trezzi I; Monfrini E; Ricciardi L; Albanese A; Avenali M; Barone P; Bentivoglio AR; Bonifati V; Bove F; Bonanni L; Brusa L; Cereda C; Cossu G; Criscuolo C; Dati G; De Rosa A; Eleopra R; Fabbrini G; Fadda L; Garbellini M; Minafra B; Onofrj M; Pacchetti C; Palmieri I; Pellecchia MT; Petracca M; Picillo M; Pisani A; Vallelunga A; Zangaglia R; Di Fonzo A; Morgante F; Valente EM;
    Mov Disord; 2020 Nov; 35(11):2106-2111. PubMed ID: 32658388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and genotype-phenotype correlations of GBA-related Parkinson disease in a large Chinese cohort.
    Ren J; Zhang R; Pan C; Xu J; Sun H; Hua P; Zhang L; Zhang W; Xu P; Ma C; Liu W
    Eur J Neurol; 2022 Apr; 29(4):1017-1024. PubMed ID: 34951095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Features of
    Malek N; Weil RS; Bresner C; Lawton MA; Grosset KA; Tan M; Bajaj N; Barker RA; Burn DJ; Foltynie T; Hardy J; Wood NW; Ben-Shlomo Y; Williams NW; Grosset DG; Morris HR;
    J Neurol Neurosurg Psychiatry; 2018 Jul; 89(7):702-709. PubMed ID: 29378790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in glucocerebrosidase are a major genetic risk factor for Parkinson's disease and increase susceptibility to dementia in a Flanders-Belgian cohort.
    Crosiers D; Verstraeten A; Wauters E; Engelborghs S; Peeters K; Mattheijssens M; De Deyn PP; Theuns J; Van Broeckhoven C; Cras P
    Neurosci Lett; 2016 Aug; 629():160-164. PubMed ID: 27397011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in the glucocerebrosidase gene are common in patients with Parkinson's disease from Eastern Canada.
    Han F; Grimes DA; Li F; Wang T; Yu Z; Song N; Wu S; Racacho L; Bulman DE
    Int J Neurosci; 2016; 126(5):415-21. PubMed ID: 26000814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The clinical features of Parkinson's disease in patients with mutations and polymorphic variants of GBA gene].
    Senkevich KA; Miliukhina IV; Beletskaia MV; Gracheva EV; Kudrevatykh AV; Nikolaev MA; Emelyanov AK; Kopytova AE; Timofeeva AA; Yakimovskii AF; Pchelina SN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(10):81-86. PubMed ID: 29171494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GBA Variants Influence Motor and Non-Motor Features of Parkinson's Disease.
    Jesús S; Huertas I; Bernal-Bernal I; Bonilla-Toribio M; Cáceres-Redondo MT; Vargas-González L; Gómez-Llamas M; Carrillo F; Calderón E; Carballo M; Gómez-Garre P; Mir P
    PLoS One; 2016; 11(12):e0167749. PubMed ID: 28030538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucocerebrosidase mutations influence the natural history of Parkinson's disease in a community-based incident cohort.
    Winder-Rhodes SE; Evans JR; Ban M; Mason SL; Williams-Gray CH; Foltynie T; Duran R; Mencacci NE; Sawcer SJ; Barker RA
    Brain; 2013 Feb; 136(Pt 2):392-9. PubMed ID: 23413260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Motor and non-motor features in Parkinson's Disease patients carrying GBA gene mutations.
    De Michele G; Palmieri GR; Pane C; Valente EM; Palmieri I; Dello Iacovo CDP; Cuomo N; Giglio A; De Lucia N; Fico T; Perillo S; De Michele G; De Rosa A
    Acta Neurol Belg; 2023 Feb; 123(1):221-226. PubMed ID: 36609835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucocerebrosidase mutations in Thai patients with Parkinson's disease.
    Pulkes T; Choubtum L; Chitphuk S; Thakkinstian A; Pongpakdee S; Kulkantrakorn K; Hanchaiphiboolkul S; Tiamkao S; Boonkongchuen P
    Parkinsonism Relat Disord; 2014 Sep; 20(9):986-91. PubMed ID: 24997549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parkinson's disease phenotype is influenced by the severity of the mutations in the GBA gene.
    Thaler A; Bregman N; Gurevich T; Shiner T; Dror Y; Zmira O; Gan-Or Z; Bar-Shira A; Gana-Weisz M; Orr-Urtreger A; Giladi N; Mirelman A
    Parkinsonism Relat Disord; 2018 Oct; 55():45-49. PubMed ID: 29784561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic mechanism vs genetic subtypes: The example of GBA.
    Senkevich K; Rudakou U; Gan-Or Z
    Handb Clin Neurol; 2023; 193():155-170. PubMed ID: 36803808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease.
    Neumann J; Bras J; Deas E; O'Sullivan SS; Parkkinen L; Lachmann RH; Li A; Holton J; Guerreiro R; Paudel R; Segarane B; Singleton A; Lees A; Hardy J; Houlden H; Revesz T; Wood NW
    Brain; 2009 Jul; 132(Pt 7):1783-94. PubMed ID: 19286695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A "dose" effect of mutations in the GBA gene on Parkinson's disease phenotype.
    Thaler A; Gurevich T; Bar Shira A; Gana Weisz M; Ash E; Shiner T; Orr-Urtreger A; Giladi N; Mirelman A
    Parkinsonism Relat Disord; 2017 Mar; 36():47-51. PubMed ID: 28012950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of GBA Mutations and the E326K Polymorphism With Motor and Cognitive Progression in Parkinson Disease.
    Davis MY; Johnson CO; Leverenz JB; Weintraub D; Trojanowski JQ; Chen-Plotkin A; Van Deerlin VM; Quinn JF; Chung KA; Peterson-Hiller AL; Rosenthal LS; Dawson TM; Albert MS; Goldman JG; Stebbins GT; Bernard B; Wszolek ZK; Ross OA; Dickson DW; Eidelberg D; Mattis PJ; Niethammer M; Yearout D; Hu SC; Cholerton BA; Smith M; Mata IF; Montine TJ; Edwards KL; Zabetian CP
    JAMA Neurol; 2016 Oct; 73(10):1217-1224. PubMed ID: 27571329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucocerebrosidase activity in Parkinson's disease with and without GBA mutations.
    Alcalay RN; Levy OA; Waters CC; Fahn S; Ford B; Kuo SH; Mazzoni P; Pauciulo MW; Nichols WC; Gan-Or Z; Rouleau GA; Chung WK; Wolf P; Oliva P; Keutzer J; Marder K; Zhang X
    Brain; 2015 Sep; 138(Pt 9):2648-58. PubMed ID: 26117366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presenting symptoms of GBA-related Parkinson's disease.
    Kresojević N; Janković M; Petrović I; Kumar KR; Dragašević N; Dobričić V; Novaković I; Svetel M; Klein C; Pekmezović T; Kostić VS
    Parkinsonism Relat Disord; 2015 Jul; 21(7):804-7. PubMed ID: 25957717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucocerebrosidase gene mutations are associated with Parkinson's disease in southern Italy.
    De Marco EV; Annesi G; Tarantino P; Rocca FE; Provenzano G; Civitelli D; Cirò Candiano IC; Annesi F; Carrideo S; Condino F; Nicoletti G; Messina D; Novellino F; Morelli M; Quattrone A
    Mov Disord; 2008 Feb; 23(3):460-3. PubMed ID: 18074383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GBA Variants in Parkinson's Disease: Clinical, Metabolomic, and Multimodal Neuroimaging Phenotypes.
    Greuel A; Trezzi JP; Glaab E; Ruppert MC; Maier F; Jäger C; Hodak Z; Lohmann K; Ma Y; Eidelberg D; Timmermann L; Hiller K; Tittgemeyer M; Drzezga A; Diederich N; Eggers C
    Mov Disord; 2020 Dec; 35(12):2201-2210. PubMed ID: 32853481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Revisiting the non-Gaucher-GBA-E326K carrier state: Is it sufficient to increase Parkinson's disease risk?
    Goldstein O; Gana-Weisz M; Cohen-Avinoam D; Shiner T; Thaler A; Cedarbaum JM; John S; Lalioti M; Gurevich T; Bar-Shira A; Mirelman A; Giladi N; Orr-Urtreger A
    Mol Genet Metab; 2019 Dec; 128(4):470-475. PubMed ID: 31662221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.